Skip to content
Menu

Aptevo Therapeutics Q3 EPS $(5.19) Misses $(3.89) Estimate

Benzinga Newsdesk 2 days ago

NewsEarningsEarnings Misses

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Aptevo Therapeutics (NASDAQ:APVO) reported quarterly losses of $(5.19) per share which missed the analyst consensus estimate of $(3.89) by 33.42 percent. This is a 87.07 percent increase over losses of $(40.14) per

Aptevo Therapeutics (NASDAQ:APVO) reported quarterly losses of $(5.19) per share which missed the analyst consensus estimate of $(3.89) by 33.42 percent. This is a 87.07 percent increase over losses of $(40.14) per share from the same period last year.

Read at benzinga.com